Cargando…

Emerging roles of the gut microbiota in cancer immunotherapy

Gut microbiota represents a hidden treasure vault encompassing trillions of microorganisms that inhabit the intestinal epithelial barrier of the host. In the past decade, numerous in-vitro, animal and clinical studies have revealed the profound roles of gut microbiota in maintaining the homeostasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Zhuangzhuang, Li, Hongwen, Song, Wenting, Zhou, Zhiyuan, Li, Zhaoming, Zhang, Mingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992551/ https://www.ncbi.nlm.nih.gov/pubmed/36911704 http://dx.doi.org/10.3389/fimmu.2023.1139821

Ejemplares similares

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
por: Li, Hongwen, et al.
Publicado: (2022)

Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
por: Qiu, Qin, et al.
Publicado: (2021)

Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms
por: Shi, Zhuangzhuang, et al.
Publicado: (2021)

The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
por: Wang, Meiqi, et al.
Publicado: (2023)

PB2388: ALTERATIONS OF THE GUT MICROBIOTA AS A NON-INVASIVE DIAGNOSTIC BIOMARKER FOR NATURAL KILLER/T-CELL LYMPHOMA
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma
por: Li, Hongwen, et al.
Publicado: (2023)

Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
por: Hou, Xinxin, et al.
Publicado: (2022)

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
por: Li, Hongwen, et al.
Publicado: (2023)

Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
por: Wu, Jianmin, et al.
Publicado: (2021)

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
por: Xue, Xiaoyu, et al.
Publicado: (2023)

The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
por: Feng, Xiaoli, et al.
Publicado: (2023)

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
por: Liu, Xiangjun, et al.
Publicado: (2021)

The Role of the Gut Microbiota in the Development of Ischemic Stroke
por: Wang, Jinchen, et al.
Publicado: (2022)

The role of gut microbiota in liver regeneration
por: Xu, Zhe, et al.
Publicado: (2022)

The gut-lung axis in influenza A: the role of gut microbiota in immune balance
por: Ou, Guosen, et al.
Publicado: (2023)

The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
por: Wang, Li, et al.
Publicado: (2022)

PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma
por: Wu, Jiazhuo, et al.
Publicado: (2023)

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Shi, Zhuangzhuang, et al.
Publicado: (2021)

Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021)
por: Yang, Shanshan, et al.
Publicado: (2022)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

The Role of Gut Microbiota in Tumor Immunotherapy
por: Wu, Miao, et al.
Publicado: (2021)

Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases
por: Mangalam, Ashutosh K., et al.
Publicado: (2020)

Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?
por: Pecora, Francesco, et al.
Publicado: (2020)

High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma
por: Chen, Yanfang, et al.
Publicado: (2022)

Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy
por: Zheng, Zhuangzhuang, et al.
Publicado: (2023)

Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
por: Shui, Lin, et al.
Publicado: (2020)

Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
por: Singh, Ankita, et al.
Publicado: (2023)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity
por: Chen, Jingxian, et al.
Publicado: (2023)

The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease
por: Gill, Paul A., et al.
Publicado: (2022)

The emerging role of oral microbiota in oral cancer initiation, progression and stemness
por: Saikia, Partha Jyoti, et al.
Publicado: (2023)

Emerging Role of Diet and Microbiota Interactions in Neuroinflammation
por: Janakiraman, Mathangi, et al.
Publicado: (2018)

Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
por: Wei, Yibing, et al.
Publicado: (2023)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Gut Microbiota, Leaky Gut, and Autoimmune Diseases
por: Christovich, Anna, et al.
Publicado: (2022)

Gut Microbiota and Immunotherapy
por: Xu, Xiaoqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_800cuc14p10otcss1h2cmqga4q